Answers are grounded in this paper and cite their sources.
The combination of rivaroxaban plus aspirin compared with aspirin alone reduces the risk of major adverse cardiovascular and limb events for high-risk patients with peripheral artery disease. It is unknown whether rivaroxaban plus aspirin improves intermittent claudication for adults with lower-risk peripheral arterial disease.
No takes yet. Share an insight, caveat, or question.
Ramacciotti et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: